An overview of carbapenemase producing enterobacteriaceae (CPE) in trauma and orthopaedics.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 31680730.
- Also identified by DOI 10.1016/j.jor.2019.06.026 and PMC identifier 6818357.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Carbapenemase resistant enterobacteriae (CPE) may be found in asymptomatic carriers. Its incidence is increasing worldwide. Surgical patients are at increased risk of immunocompromise and of carriage progressing to active infection. Active infection with CPE caries a high mortality rate, with the bacteria being resistant to many antibiotics. This article provides details on the epidemiology, screening and management of the orthopaedic patient with CPE. The guidelines advise orthopaedic staff on ways to avoid the spread of CPE amongst inpatients.